Akebia plans to initiate the Phase III VALOR trial for Vafseo in non-dialysis CKD patients in H2 2025. The trial design is being finalized in consultation with the FDA.

Originally planned for a Winter 2024 release, the delay came as a response to a "crowded ARPG release window." ...

Titan Quest II missed its Early Access launch window, so a new window has been announced, but still no firm date confirmed ...

Subtle signs of elder abuse like withdrawal or financial strain are often overlooked Learn how to spot early red flags and ...

With winter over and spring in effect, publisher THQ Nordic and developer Grimlore Games have officially delayed the Early Access launch of Titan Quest II for PC via Steam from its previously ...

It's tempting to dip into your 401(k) at 55, which you can do without a penalty under some circumstances. But beware — you ...

The group announced “The Song Is Over,” their “bittersweet final tour of the US and Canada as a truly grand finale of their ...

Just after passing its first year in early access, action-RPG No Rest For The Wicked is making a major change by scrapping ...

With over 200,000 wishlists, a Top 10 Global Seller debut, and over 100,000 players in the first week, Deadzone: Rogue has ...

Building an AI company isn’t just another startup journey—it demands unique strategies, technical rigor and ethical foresight ...

Don't miss the Early Access Update 0.2 Launch Trailer for Assetto Corsa EVO, the hit racing simulation game developed by ...

Take on the taks of colonizing Mars with friends in a co-op mission, as Horizon Journey will be coming to Early Access in ...